Published in J Clin Oncol on February 01, 2010
Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer. South Asian J Cancer (2017) 0.75
Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma (2007) 2.55
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res (2008) 2.42
Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia. J Clin Oncol (2009) 1.60
Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature. Expert Opin Ther Targets (2010) 1.48
Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis. Med Hypotheses (2004) 1.42
Manipulating the chemokine-chemokine receptor network to treat cancer. Cancer (2007) 1.38
Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer. Med Oncol (2010) 1.16
Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis. Leuk Lymphoma (2009) 1.09
EGFR expression and gene copy number in triple-negative breast carcinoma. Cancer Genet Cytogenet (2010) 1.08
Association between common risk factors and molecular subtypes in breast cancer patients. Breast (2012) 1.06
Unusual location of hydatid cyst: soft tissue mass in the neck. Eur Arch Otorhinolaryngol (2006) 1.01
Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors. J Oral Maxillofac Surg (2006) 1.00
Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy. Cancer Invest (2007) 1.00
Cardiotoxicity of novel HER2-targeted therapies. Curr Med Res Opin (2013) 0.97
From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures. Eur J Cancer Prev (2008) 0.96
Stem cell-related markers in primary breast cancers and associated metastatic lesions. Mod Pathol (2012) 0.95
Systemic treatment in breast-cancer patients with brain metastasis. Expert Opin Pharmacother (2010) 0.95
A case report: zoledronic acid-induced anterior uveitis. Med Oncol (2007) 0.94
Pertuzumab in HER2-positive breast cancer. Curr Med Res Opin (2012) 0.94
Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma. Med Oncol (2010) 0.94
Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer. Curr Med Res Opin (2013) 0.93
Iliopsoas muscle injury during a femoral artery puncture: benign but disabling. J Crit Care (2003) 0.92
Metaplastic breast carcinoma: a heterogeneous disease. Asian Pac J Cancer Prev (2014) 0.92
Breast cancer subtypes and outcomes of central nervous system metastases. Breast (2011) 0.92
Zoledronic acid and atrial fibrillation in cancer patients. Support Care Cancer (2010) 0.92
Hormone receptor status in patients with breast cancer and liver metastases treated with laser-induced intersititial thermotherapy. Radiology (2005) 0.91
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer. Breast Cancer Res (2007) 0.91
Anterior abdominal wall synovial sarcoma: a rare presentation. Am J Clin Oncol (2005) 0.91
Warfarin-induced skin necrosis and leukocytoclastic vasculitis in a patient with acquired protein C and protein S deficiency. Blood Coagul Fibrinolysis (2007) 0.90
Characteristics of breast cancer patients with central nervous system metastases: a single-center experience. J Natl Med Assoc (2008) 0.90
Brain metastasis of cardiac myxoma: case report and review of the literature. J Neurooncol (2005) 0.90
Possible association between nanobacteria and malignant microcalcifications in breast cancer. Breast J (2006) 0.89
Orbital metastasis from adenocarcinoma of the colon. South Med J (2005) 0.88
Trastuzumab in metastatic breast cancer after complete remission: How long is enough? Med Oncol (2015) 0.88
Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer. Med Oncol (2010) 0.88
Optimal timing of adjuvant treatment in patients with early breast cancer. Med Oncol (2010) 0.87
Demographic and clinico-pathological characteristics in patients with invasive breast cancer receiving metformin. Med Oncol (2013) 0.86
Ductal carcinoma in situ and bilateral atypical ductal hyperplasia in a 23-year-old man with gynecomastia. Am Surg (2011) 0.86
Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes. Med Oncol (2013) 0.86
Angiotensin-converting enzyme inhibitors for bevacizumab-induced hypertension. Ann Pharmacother (2006) 0.85
Leptin and breast cancer: an overview. Med Oncol (2011) 0.84
Impact of inflammatory markers on the prognosis of patients with operable breast cancer. J BUON (2014) 0.84
Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer. Med Oncol (2007) 0.84
Blood ABO groups and risk of breast cancer. Med Oncol (2010) 0.84
Herpes simplex type-2 encephalitis masked by diabetic ketoacidosis. J Natl Med Assoc (2005) 0.84
The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach. Cancer (2004) 0.84
Preoperative Doppler sonography for prevention of perioperative stroke in head and neck cancer patients undergoing neck dissection: is it beneficial? J Clin Ultrasound (2007) 0.84
Treatment of recurrent cerebellar hemangioblastoma with external radiotherapy in a patient with von Hippel-Lindau disease: a case report and review of the literature. J Neurooncol (2005) 0.84
Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy. Urol Oncol (2012) 0.83
Isolated granulocytic sarcoma of the head and neck preceding acute myeloid leukemia. Am J Hematol (2004) 0.83
Pharmacotherapy of triple-negative breast cancer. Expert Opin Pharmacother (2009) 0.83
Interleukin-6 and C-reactive protein in metastatic renal cell carcinoma. J Clin Oncol (2005) 0.83
Clinical characteristics and outcome of patients with stage III esophageal carcinoma: a single-center experience from Turkey. Med Oncol (2007) 0.82
Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastases. Med Oncol (2008) 0.82
Emerging drugs in metastatic breast cancer. Expert Opin Emerg Drugs (2009) 0.82
The efficacy of adjuvant trastuzumab in HER-2 positive breast cancer with axillary lymph node metastases according to the treatment duration. Curr Med Res Opin (2014) 0.82
Good outcomes of patients with stage IB endometrial cancer with surgery alone. Asian Pac J Cancer Prev (2014) 0.81
Brucella glomerulonephritis: case report and review of the literature. South Med J (2005) 0.81
Association between obesity and multiple myeloma in postmenopausal women may be attributed to increased aromatization of androgen in adipose tissue. Med Hypotheses (2005) 0.81
Comparison of the long term cardiac effects associated with 9 and 52 weeks of trastuzumab in HER2-positive early breast cancer. Curr Med Res Opin (2015) 0.81
Embryonal rhabdomyosarcoma of the larynx. Otolaryngol Head Neck Surg (2005) 0.81
Extramedullary plasmacytoma of nasopharynx and larynx: synchronous presentation. Am J Hematol (2004) 0.81
Possible mechanisms behind taxane-anthracycline sequencing. Lancet Oncol (2010) 0.81
Fluorouracil-induced neurotoxicity presenting with generalized tonic-clonic seizure. Ann Pharmacother (2004) 0.81
"Unfit" for Cisplatin: on basis of which GFR? J Clin Oncol (2011) 0.81
Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines. Breast Cancer Res Treat (2007) 0.80
Acute tumor lysis syndrome triggered by zoledronic Acid in a patient with metastatic lung adenocarcinoma. Med Oncol (2005) 0.80
Medulloblastoma/primitive neuroectodermal tumor in adults: prognostic factors and treatment results: a single-center experience from Turkey. Med Oncol (2007) 0.80
Systemic anaphylactic reaction following intrathecal administration of methotrexate in adult patient with primary central nervous system lymphoma. Am J Hematol (2004) 0.80
A novel targeted therapy in breast cancer: cyclin dependent kinase inhibitors. J BUON (2014) 0.80
Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer (2006) 0.80
Global warming may increase the incidence and geographic range of Crimean-Congo Hemorrhagic Fever. Med Hypotheses (2006) 0.80
Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: a single center experience. Med Oncol (2012) 0.79
Granulocytic sarcoma of the urinary bladder. Am J Hematol (2004) 0.79
Can all beta blockers improve the breast cancer survival? Breast (2011) 0.79
The effect of renin-angiotensin-system inhibition on survival and recurrence of N3+ breast cancer patients. J BUON (2015) 0.79
Lymphatic and capillary invasion patterns in triple negative breast cancer. Am Surg (2012) 0.79
Erythropoiesis-stimulating agents in the treatment of cancer-associated anemia. JAMA (2008) 0.79
Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors. Breast Cancer Res Treat (2007) 0.79
Possible role of CXCR4-mediated chemotaxis in breast cancer patients with central nervous system metastases. Breast Cancer Res Treat (2005) 0.79
Invasive papillary carcinoma of the breast: an overview of twenty-four cases. Am Surg (2012) 0.79
Association of breast cancer subtypes and body mass index. Tumori (2013) 0.79
Everolimus: a new hope for patients with breast cancer. Curr Med Res Opin (2013) 0.79